Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Schwartz

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
The Milbank Memorial Fund Quarterly. Health and Society|January 1, 1976
Societal responsibility for malpracticeD H Schwartz
Immunology Today|February 1, 1994
Potential pitfalls on the road to an effective HIV vaccineD H Schwartz
The New England Journal of Medicine|December 28, 1995
Early treatment of HIV infectionD H Schwartz
Hospital Progress|May 1, 1970
How a merger affected the purchasing functionD H Schwartz, R Ambrose
Pharmacology, Biochemistry, and Behavior|November 1, 1988
Effect of phenylpropanolamine on diet selection in ratsD H Schwartz, B G Hoebel
The Journal of Experimental Medicine|September 1, 1982
Induction of neonatal tolerance to H-2k in B6 mice does not allow the emergence of T cells specific for H-2k plus vaccinia virusD H Schwartz, P C Doherty
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
Virus-immune and alloreactive response characteristics of thymocytes and spleen cells from young miceD H Schwartz, P C Doherty
Thymus|January 1, 1984
Induction of early alloantigen tolerance in thymus and spleenD H Schwartz, P C Doherty
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Interleukin-2 in the treatment of HIV diseaseD H Schwartz, T C Merigan
Journal of Virology|May 30, 1998
Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cellsS Iyengar, J E Hildreth, D H Schwartz
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
The Milbank Memorial Fund Quarterly. Health and Society|January 1, 1976
Societal responsibility for malpracticeD H Schwartz
Immunology Today|February 1, 1994
Potential pitfalls on the road to an effective HIV vaccineD H Schwartz
The New England Journal of Medicine|December 28, 1995
Early treatment of HIV infectionD H Schwartz
Hospital Progress|May 1, 1970
How a merger affected the purchasing functionD H Schwartz, R Ambrose
Pharmacology, Biochemistry, and Behavior|November 1, 1988
Effect of phenylpropanolamine on diet selection in ratsD H Schwartz, B G Hoebel
The Journal of Experimental Medicine|September 1, 1982
Induction of neonatal tolerance to H-2k in B6 mice does not allow the emergence of T cells specific for H-2k plus vaccinia virusD H Schwartz, P C Doherty
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
Virus-immune and alloreactive response characteristics of thymocytes and spleen cells from young miceD H Schwartz, P C Doherty
Thymus|January 1, 1984
Induction of early alloantigen tolerance in thymus and spleenD H Schwartz, P C Doherty
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Interleukin-2 in the treatment of HIV diseaseD H Schwartz, T C Merigan
Journal of Virology|May 30, 1998
Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cellsS Iyengar, J E Hildreth, D H Schwartz
Pageof 7